THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT by Anuj Mahindra, Jacob Laubach, Paul Richardson, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson

Get full text

The Rapidly Evolving Treatment Landscape in Newly Diagnosed Multiple Myeloma: Current Status and Future Directions by Yuxin Liu, Clifton Mo, Monique Hartley-Brown, Shonali Midha, Adam S. Sperling, Giada Bianchi, Omar Nadeem, Betsy O’Donnell, Jacob Laubach, Paul G. Richardson

Get full text

The Evolving Role of Alkylating Agents in Multiple Myeloma: From the Past and Present to Next-Generation Peptide Drug Conjugates by Yuxin Liu, Shahrier Hossain, Omar Nadeem, Shonali Midha, Monique Hartley-Brown, Taya Salman, Pedro Vianna, Adam S. Sperling, Giada Bianchi, Clifton Mo, Jacob Laubach, Paul G. Richardson

Get full text

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm by Charlotte Pawlyn, Fredrik H. Schjesvold, David A. Cairns, L. J. Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos, Jacob Laubach, Katja Weisel, Heinz Ludwig, S. Vincent Rajkumar, Pieter Sonneveld, Graham Jackson, Gareth Morgan, Paul G. Richardson

Get full text